Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claus Vogelmeier

Showing results (81-90 of 158) with videos related to

Pageof 16
Sort By:
The European Respiratory Journal|December 16, 2014
Nebulised budesonide using a novel device in patients with oral steroid-dependent asthmaClaus Vogelmeier, Peter Kardos, Thomas Hofmann, et al.
Pharmacoeconomics|July 1, 2005
Economic assessment of adjustable maintenance treatment with budesonide/formoterol in a single inhaler versus fixed treatment in asthmaBernd Brüggenjürgen, Dagmar Selim, Peter Kardos, et al.
Respirology (Carlton, Vic.)|December 2, 2009
Ambient temperature impacts on pH of exhaled breath condensateAndreas R Koczulla, Sarah Noeske, Christian Herr, et al.
Respiratory Medicine|August 30, 2011
Alpha-1 antitrypsin is elevated in exhaled breath condensate and serum in exacerbated COPD patientsA Rembert Koczulla, Sarah Noeske, Christian Herr, et al.
Journal of Breath Research|October 31, 2017
Obstructive sleep apnea patients can be identified by ion mobility spectrometry-derived smell prints of different biological materialsTimm Greulich, Hannes Fischer, Dirk Lubbe, et al.
Respiratory Medicine|March 15, 2012
Perspectives for improving the evaluation and access of therapies for rare lung diseases in EuropeMaurizio Luisetti, Ian M Balfour-Lynn, Simon R Johnson, et al.
Respiration; International Review of Thoracic Diseases|February 6, 2010
Impact of different definitions of airflow limitation on the prevalence of chronic obstructive pulmonary disease in the general populationSven Gläser, Christoph Schäper, Anne Obst, et al.
Respiratory Research|December 15, 2018
Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trialHenrik Watz, Kay Tetzlaff, Helgo Magnussen, et al.
Experimental Lung Research|February 20, 2004
Recombinant Sendai virus for efficient gene transfer to human airway epitheliumOlaf Pinkenburg, Claus Vogelmeier, Sascha Bossow, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 17, 2019
Determinants of healthcare utilization and costs in COPD patients: first longitudinal results from the German COPD cohort COSYCONETDanalyn Byng, Johanna I Lutter, Margarethe E Wacker, et al.
Pageof 16

Showing results (81-90 of 158) with videos related to

Sort By:
Pageof 16
The European Respiratory Journal|December 16, 2014
Nebulised budesonide using a novel device in patients with oral steroid-dependent asthmaClaus Vogelmeier, Peter Kardos, Thomas Hofmann, et al.
Pharmacoeconomics|July 1, 2005
Economic assessment of adjustable maintenance treatment with budesonide/formoterol in a single inhaler versus fixed treatment in asthmaBernd Brüggenjürgen, Dagmar Selim, Peter Kardos, et al.
Respirology (Carlton, Vic.)|December 2, 2009
Ambient temperature impacts on pH of exhaled breath condensateAndreas R Koczulla, Sarah Noeske, Christian Herr, et al.
Respiratory Medicine|August 30, 2011
Alpha-1 antitrypsin is elevated in exhaled breath condensate and serum in exacerbated COPD patientsA Rembert Koczulla, Sarah Noeske, Christian Herr, et al.
Journal of Breath Research|October 31, 2017
Obstructive sleep apnea patients can be identified by ion mobility spectrometry-derived smell prints of different biological materialsTimm Greulich, Hannes Fischer, Dirk Lubbe, et al.
Respiratory Medicine|March 15, 2012
Perspectives for improving the evaluation and access of therapies for rare lung diseases in EuropeMaurizio Luisetti, Ian M Balfour-Lynn, Simon R Johnson, et al.
Respiration; International Review of Thoracic Diseases|February 6, 2010
Impact of different definitions of airflow limitation on the prevalence of chronic obstructive pulmonary disease in the general populationSven Gläser, Christoph Schäper, Anne Obst, et al.
Respiratory Research|December 15, 2018
Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trialHenrik Watz, Kay Tetzlaff, Helgo Magnussen, et al.
Experimental Lung Research|February 20, 2004
Recombinant Sendai virus for efficient gene transfer to human airway epitheliumOlaf Pinkenburg, Claus Vogelmeier, Sascha Bossow, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 17, 2019
Determinants of healthcare utilization and costs in COPD patients: first longitudinal results from the German COPD cohort COSYCONETDanalyn Byng, Johanna I Lutter, Margarethe E Wacker, et al.
Pageof 16